Projekt Übersicht: 2018 – 2022
SFB-TR 84 “Angeborene Immunität der Lunge: Mechanismen des Pathogenangriffs und der Wirtsabwehr in der Pneumonie“
|
Area A Pathogen recognition in the lung and initiation of innate immune response |
Area B Humoral and cell-based bronchoalveolar defense mechanisms |
Area C Control of host response in the bronchoalveolar compartment and strategies for intervention |
|
A1 – Opitz / Diefenbach Regulation of antibacterial defense in the lung by the alarmin IL-33 |
B2 – Peteranderl / Wolff Stabilization of epithelial integrity in influenza virus pneumonia: role of death ligands and their downstream effectors |
C1 – Schmeck / Marsico RNA-mediated regulatory networks in Legionella pneumophila pneumonia |
|
A2 – Wygrecka / Kübler / Hackstein Coagulation factor XII – a novel regulator of immune responses and barrier function in pneumonia |
||
|
A4 – Pillich / Chakraborty / Hippenstiel Pathophysiological host-pathogen crosstalk of Streptococcus pneumoniae at lung barrier interfaces |
B6 – Hocke /Hippenstiel / Antelmann Bacterial acidification as a new virulence mechanism for immune activation and barrier failure via mitochondrial dysfunction |
C6 – Witzenrath / Weissmann Lung protection in severe pneumonia by means of Tie2 agonism |
|
A5 – Opitz / Chaput / Heimesaat Cross-talk of antimicrobial therapy, microbiota and innate immunity in pneumonia |
C8 – Seeberger / Sander Novel glyco-conjugate vaccine strategies against bacterial pneumonia |
|
|
A6 – Kummer / Diefenbach Pathogen recognition by taste and odorant receptors and coupling to BALT formation and epithelial remodeling |
B8 – Hain / Mall Therapeutic targeting of airway microbiome in mice with cystic fibrosis-like lung disease to prevent lung damage and pneumonia |
C9 – Kübler / Suttorp / Witzenrath Role of CFTR and its downstream signaling in lung barrier failure in pneumonia |
|
A7 – Drosten / Hönzke Modulation of infection and defense by MERS-coronavirus protein 4b |
B9 – Herold / Triantafyllopulou Regulation of macrophage reprogramming and functional specification in pneumonia |
C10 – Sander / Schulte / Bauer Long non-coding RNAs and RNA editing in antibacterial host defense in the lung |
|
Area Z: Service Projects |
|
|
Z1a – Hocke High-end microscopy and digital image analysis in cellular microbiology of the lung |
Z1b – Gruber Experimental histopathology, advanced histomorphometrical digital image analysis, molecular pathology and tissue banking |
Management – Coordination
-
M.A. Anna-Kathrin Oswald
Charité – Universitätsmedizin Berlin
Med. Klinik m.S. Infektiologie und Pneumologie
Augustenburger Platz 1
13353 Berlin
- fon
- 030/ 450 653 579
- sfb-tr84@charite.de
-
M.A. Katharina Richter
Charité – Universitätsmedizin Berlin
Med. Klinik m.S. Infektiologie und Pneumologie
Augustenburger Platz 1
13353 Berlin
- fon
- 030/ 450 553006
- sfb-tr84@charite.de
-
Prof. Dr. med. Norbert Suttorp
Charité – Universitätsmedizin Berlin
Medizinische Klinik mit Schwerpunkt Infektiologie und Pneumologie
Augustenburger Platz 1
13353 Berlin
- fon
- 030-450 553 051
- norbert.suttorp@charite.de
Cooperation








charite.de